More Incyte Corporation news Incyte CorporationNASDAQ: INCY Incyte Announces New Data for Ruxolitinib Cream (Opzelura®) in Children with Atopic Dermatitis Oct 13, 2023 · Issued by Incyte Corporation As issuedPlain English Watch Incyte explain it↗Incyte Corporation (INCY) Q2 2026 Earnings Call · Replay · Jul 28 - In the TRuE-AD3 trial, children (age ≥2 to
